Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Evaluation of a patient self-stratification methodology to identify those in need of shielding during COVID-19.

Literature DB >> 32917745

Evaluation of a patient self-stratification methodology to identify those in need of shielding during COVID-19.

Elizabeth Reilly¹, Sarah Skeoch², Sarah Hardcastle², John D Pauling³, Megan Rowe², Tehseen Ahmed², Andrew Allard², Bashaar Boyce², Ellie Korendowych², Chloe Lapraik², William Tillett³, Raj Sengupta².

Abstract

The logistical challenges of rapidly and accurately identifying those patients who needed to shield during the COVID-19 pandemic were unprecedented. We report our experiences of meeting this challenge for >9,000 patients with rheumatic and musculoskeletal disease at our centre, incorporating an element of guided patient self-stratification. Our results indicate that patients are able to stratify their own risk accurately using the BSR COVID-19 risk stratification guidance.

Entities: Disease Species

Keywords: British Society for Rheumatology; COVID-19; rheumatic and musculoskeletal disease; service evaluation

Mesh：

Year: 2020 PMID： 32917745 PMCID： PMC7687346 DOI： 10.7861/clinmed.2020-0469

Source DB: PubMed Journal: Clin Med (Lond) ISSN： 1470-2118 Impact factor: 2.659

9 in total

1. American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 1.

Authors: Ted R Mikuls; Sindhu R Johnson; Liana Fraenkel; Reuben J Arasaratnam; Lindsey R Baden; Bonnie L Bermas; Winn Chatham; Stanley Cohen; Karen Costenbader; Ellen M Gravallese; Andre C Kalil; Michael E Weinblatt; Kevin Winthrop; Amy S Mudano; Amy Turner; Kenneth G Saag
Journal: Arthritis Rheumatol Date: 2020-06-05 Impact factor: 10.995

2. Burden of Serious Infections in Adults With Systemic Lupus Erythematosus: A National Population-Based Study, 1996-2011.

Authors: Maria G Tektonidou; Zhong Wang; Abhijit Dasgupta; Michael M Ward
Journal: Arthritis Care Res (Hoboken) Date: 2015-08 Impact factor: 4.794

3. Serious infections among adult Medicaid beneficiaries with systemic lupus erythematosus and lupus nephritis.

Authors: Candace H Feldman; Linda T Hiraki; Wolfgang C Winkelmayer; Francisco M Marty; Jessica M Franklin; Seoyoung C Kim; Karen H Costenbader
Journal: Arthritis Rheumatol Date: 2015-06 Impact factor: 10.995

4. Herpes zoster infections in systemic lupus erythematosus: risk factors and outcome.

Authors: L E Kahl
Journal: J Rheumatol Date: 1994-01 Impact factor: 4.666

Review 5. The risk of infections with biologic therapies for rheumatoid arthritis.

Authors: Daniel E Furst
Journal: Semin Arthritis Rheum Date: 2008-12-31 Impact factor: 5.532

6. Identifying rheumatic disease patients at high risk and requiring shielding during the COVID-19 pandemic.

Authors: Elizabeth Price; Elizabeth MacPhie; Lesley Kay; Peter Lanyon; Bridget Griffiths; Christopher Holroyd; Abhishek Abhishek; Taryn Youngstein; Kathryn Bailey; Jacqui Clinch; Muddassir Shaikh; Ali Rivett
Journal: Clin Med (Lond) Date: 2020-05-05 Impact factor: 2.659

2 in total

1. Rarely pure and never simple: interpreting investigation results in the clinical context.

Authors: Anton Emmanuel
Journal: Clin Med (Lond) Date: 2020-11 Impact factor: 2.659

2. Impact of Covid-19 on clinical care and lived experience of systemic sclerosis: An international survey from EURORDIS-Rare Diseases Europe.

Authors: Michael Hughes; John D Pauling; Andrew Moore; Jennifer Jones
Journal: J Scleroderma Relat Disord Date: 2021-03-16